CAS 38821-49-7
:Carbidopa monohydrate
Description:
Carbidopa monohydrate is a pharmaceutical compound primarily used in the treatment of Parkinson's disease and its symptoms. It functions as a dopa decarboxylase inhibitor, which prevents the conversion of levodopa to dopamine in the peripheral tissues, thereby increasing the availability of levodopa to the brain. This enhances the therapeutic effects of levodopa while minimizing side effects associated with peripheral dopamine production. The monohydrate form indicates that the compound contains one molecule of water for each molecule of carbidopa, which can influence its solubility and stability. Carbidopa monohydrate is typically administered in combination with levodopa to optimize treatment outcomes. It is characterized by its white to off-white crystalline appearance and is soluble in water, which facilitates its formulation in oral dosage forms. The compound is generally well-tolerated, although it may cause side effects such as nausea, dizziness, and dyskinesia in some patients. Overall, carbidopa monohydrate plays a crucial role in managing Parkinson's disease by enhancing the efficacy of levodopa therapy.
Formula:C10H14N2O4·H2O
InChI:InChI=1S/C10H14N2O4.H2O/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6;/h2-4,12-14H,5,11H2,1H3,(H,15,16);1H2/t10-;/m0./s1
InChI key:InChIKey=QTAOMKOIBXZKND-PPHPATTJSA-N
SMILES:[C@@](CC1=CC(O)=C(O)C=C1)(C(O)=O)(NN)C.O
Synonyms:- (+)-2-(3,4-Dihydroxybenzyl)-2-Hydrazinopropionic Acid Monohydrate
- 3-(3,4-Dihydroxyphenyl)-2-Hydrazinyl-2-Methylpropanoic Acid Hydrate (1:1)
- Benzenepropanoic acid, α-hydrazino-3,4-dihydroxy-α-methyl-, monohydrate, (S)-
- Benzenepropanoic acid, α-hydrazino-3,4-dihydroxy-α-methyl-, monohydrate, (αS)-
- Benzenepropanoic acid, α-hydrazinyl-3,4-dihydroxy-α-methyl-, hydrate (1:1), (αS)-
- Carbidopa monohydrate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 18 products.
Carbidopa Monohydrate
CAS:Formula:C10H14N2O4·H2OPurity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalineMolecular weight:244.25Carbidopa
CAS:CarbidopaFormula:C10H14N2O4Purity:92.4%Color and Shape:White. To. Off-WhiteMolecular weight:226.09536CARBIDOPA FOR SYSTEM SUITABILITY CRS
CAS:CARBIDOPA FOR SYSTEM SUITABILITY CRSFormula:C10H14N2O4Color and Shape:White. Whitish. Powder., White. Whitish. Powder.Molecular weight:226.2292CARBIDOPA CRS
CAS:CARBIDOPA CRSFormula:C10H14N2O4Color and Shape:White. Whitish. Powder.Molecular weight:226.2292Carbidopa
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFormula:C10H14N2O4·H2OColor and Shape:White PowderMolecular weight:226.09536Carbidopa
CAS:Formula:C10H14N2O4·xH2OPurity:(HPLC) ≥ 98.5%Color and Shape:White to light-yellow powderMolecular weight:226.23 (anhydrous)Carbidopa monohydrate
CAS:<p>Carbidopa monohydrate (S(-)-Carbidopa) is an inhibitor of DOPA decarboxylase, preventing the conversion of levodopa to dopamine.</p>Formula:C10H16N2O5Purity:98.11% - 98.30%Color and Shape:SolidMolecular weight:244.24S-(-)-Carbidopa monohydrate
CAS:Controlled Product<p>Inhibitor of peripheral decarboxylase</p>Formula:C10H14N2O4·H2OPurity:Min. 95%Color and Shape:White PowderMolecular weight:244.24 g/molCarbidopa Monohydrate
CAS:Controlled Product<p>Applications Carbidopa Monohydrate (cas# 38821-49-7) is a useful research chemical.<br></p>Formula:C10H14N2O4·H2OColor and Shape:White To Off-WhiteMolecular weight:244.24S-(-)-Carbidopa monohydrate
CAS:Controlled Product<p>Inhibitor of peripheral decarboxylase</p>Formula:C10H14N2O4•H2OPurity:Min. 95%Color and Shape:PowderMolecular weight:244.24 g/mol
